ErgomedCompany research
Click on headlines below to download research
Exiting FY22 on a strong footing
Ergomed | 21/12/2022
In the run-up to Ergomed’s FY22 trading update (expected end-January 2023), we take a fresh look at our estimates for the company and make minor…
Two key management changes
Ergomed | 18/11/2022
In a strategic move to support its business development plans and digitisation efforts, Ergomed has announced two senior appointments to its executive…
Poised for a strong FY22
Ergomed | 30/09/2022
Ergomed released full H122 accounts following its July 2022 trading update, the key takeaway of which was the sustained strong momentum across both business…
Sustained growth momentum in H122
Ergomed | 27/07/2022
Ergomed’s H122 trading update re-emphasised its robust business model and resilient growth despite the challenging macro environment. Revenues grew…